14-day Premium Trial Subscription Try For FreeTry Free
Could these pharmaceutical stocks be worth watching today?
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer

ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates

12:05pm, Tuesday, 10'th May 2022 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of -250% and 1.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive O
ANI (ANIP) delivered earnings and revenue surprises of -250% and 1.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates

01:15pm, Monday, 09'th May 2022 Zacks Investment Research
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -26.87% and 8.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates

12:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -76.58% and 8.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tu

This Pharmaceutical Stock Can Make You Very Rich

03:24pm, Saturday, 26'th Mar 2022
Pharmaceutical stocks are great wealth builders. But you need to discover how to use them and what to avoid.
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809.09. The S&P also rose, gaining, 1.24% to 4,224.97. Also check this: Executives Sell More Than $25M Of 4 Stocks Leading and Lagging Sectors Consumer discretionary shares climbed by 2.7% on Tuesday. Meanwhile, top gainers in the sector included New Oriental Education & Technology Group Inc. (NYSE: EDU ), up 20% and Shift Technologies, Inc. (NASDAQ: SFT ) up 15%. In trading on Tuesday, energy shares fell by 3.3%. Top Headline US producer prices rose 0.8% from a month ago in February, versus a revised 1.2% increase in the previous month and slightly below analysts’ estimates of 0.9%. Equities Trading UP Incannex Healthcare Limited (NASDAQ: IXHL ) shares shot up 136% to $54.00 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA).

ANI Pharmaceuticals Down 25% After Earnings Miss

04:59pm, Tuesday, 15'th Mar 2022 Investing.com
https://www.investing.com/news/stock-market-news/ani-pharmaceuticals-down-25-after-earnings-miss-2785166

ANI Pharma reaches a seven-month low on soft guidance for 2022

02:27pm, Tuesday, 15'th Mar 2022 Seeking Alpha
The shares of ANI Pharmaceuticals <> have approached the lowest level since August after the maker of branded and generic medicines posted a lower than expected guidance for 2022
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
ANI Pharmaceuticals Inc''s (NASDAQ: ANIP ) Q4 revenues were $60.9 million , +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for generic pharmaceutical products were $41.6 million, +8% primarily due to the Novitium acquisition and Q3 launch of Nebivolol, tempered by sales declines for Tolterodine and Vancomycin and lower … Full story available on Benzinga.com
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE